Skip to main content

Table 1 Clinical characteristics of the patients.

From: Combined measurement of soluble and cellular ICAM-1 among children with Plasmodium falciparum malaria in Uganda

 

All patients

n = 160

Uncomplicated malaria

out-patients (UM),

n = 53

Severe malaria survivors

(SM-s)

n = 80

Fatal malaria (SM-f),* n = 27

Age (years) median (IQR)

2.2 (1.2 - 4.4)

4.4 (2.2 - 8)

1.6 (1 - 3.1)

1.9 (1.2-3.4)

Sex (female:male)

79:81

24:29

37:43

18:9

# of days ill prior to presentation median (IQR)

3 (3-4)

3 (2-4)

3 (3-4)

4 (2-6.5)

Haemoglobin (g/dL) median (IQR)

6.3 (4.2-9.6)

10.1 (9.4 - 11.3)

4.4 (3.4 - 5.6)

5.9 (4.6 - 8.5)

WBC/μL

median (IQR)

10,200 (6,800 - 14,300)

7,500 (5,200 - 9,000)

12,150 (9,375 - 16,000)

13,000 (8,500 - 25,125)

Monocytes/μL

median (IQR)

66 (39 - 114)

48 (33 - 63)

94 (50 - 137)

83 (51 - 125)

Parasitized red cells/μL

median (IQR)

39,600 (11,405-150,830)

37,680 (18,140-115,000)

37,010 (7,500-151,095)

118,920 (24,000-271,350)

# with cerebral malaria

39

0

24

15

# with severe malaria anaemia

54

0

47

7

# with both cerebral malaria and severe malaria anaemia

11

0

9

2

  1. Patients with cerebral malaria or severe malaria anaemia are a subset of those with fatal or severe disease.
  2. * Three patients with fatal malaria did not meet criteria for cerebral malaria or severe malarial anaemia.